Have a personal or library account? Click to login
Potassium channel inhibitors induce oxidative stress in breast cancer cells Cover

Potassium channel inhibitors induce oxidative stress in breast cancer cells

Open Access
|Mar 2018

References

  1. Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, ME LL. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013; 12:376–90.10.1016/j.arr.2012.10.00423123177
  2. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12:931–47.2428778110.1038/nrd4002
  3. Gupta R, Sikka SC. Prostate cancer and oxidative stress. In: Laher I, editor. Systems biology of free radicals and antioxidants. Berlin: Springer-Verlag; 2014. p. 2835–50.
  4. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007; 121:2381–6.1789386810.1002/ijc.23192
  5. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011; 11:85–95.10.1038/nrc298121258394
  6. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458:780–3.10.1038/nature0773319194462
  7. Hecht F, Pessoa CF, Gentile LB, Rosenthal D, Carvalho DP, Fortunato RS. The role of oxidative stress on breast cancer development and therapy. Tumour Biol. 2016; 37:4281–91.10.1007/s13277-016-4873-9
  8. Hernandes MS, Troncone LRP. Glycine as a neurotransmitter in the forebrain: a short review. J Neural Transm (Vienna). 2009; 116:1551–60.10.1007/s00702-009-0326-6
  9. Leanza L, Zoratti M, Gulbins E, Szabo I. Mitochondrial ion channels as oncological targets. Oncogene. 2014; 33:5569–81.10.1038/onc.2013.57824469031
  10. Villalonga N, Ferreres JC, Argilés JM, Condom E, Felipe A. Potassium channels are a new target field in anticancer drug design. Recent Pat Anticancer Drug Discov. 2007; 2:212–23.1822106410.2174/157489207782497181
  11. Leanza L, Managò A, Zoratti M, Gulbins E, Szabo I. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences. Biochim Biophys Acta. 2016; 1863:1385–97.2665864210.1016/j.bbamcr.2015.11.032
  12. Urrego D, Tomczak AP, Zahed F, Stühmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci. 2014; 369:20130094, 10.1098/rstb.2013.0094.24493742
  13. Jang SH, Choi SY, Ryu PD, Lee SY. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol. 2011; 651:26–32.2108760210.1016/j.ejphar.2010.10.066
  14. Borowiec AS, Hague F, Harir N, Guénin S, Guerineau F, Gouilleux F, et al. IGF-1 activates hEAG K+ channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. J Cell Physiol. 2007; 212:690–701.10.1002/jcp.2106517520698
  15. Brevet M, Ahidouch A, Sevestre H, Merviel P, El Hiani Y, Robbe M, et al. Expression of K+ channels in normal and cancerous human breast. Histol Histopathol. 2008; 23:965–72.18498071
  16. So EC, Huang Y-M, Hsing C-H, Liao Y-K, Wu S-N. Arecoline inhibits intermediate-conductance calcium-activated potassium channels in human glioblastoma cell lines. Eur J Pharmacol. 2015; 758:177–87.2584341410.1016/j.ejphar.2015.03.065
  17. Leanza L, Venturini E, Kadow S, Carpinteiro A, Gulbins E, Becker KA. Targeting a mitochondrial potassium channel to fight cancer. Cell Calcium. 2015; 58:131–8.10.1016/j.ceca.2014.09.00625443654
  18. Hu L, Pennington M, Jiang Q, Whartenby KA, Calabresi PA. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J Immunol. 2007; 179:4563–70.10.4049/jimmunol.179.7.456317878353
  19. García-Quiroz J, Camacho J. Astemizole: an old anti-histamine as a new promising anti-cancer drug. Anticancer Agents Med Chem. 2011; 11:307–14.2144350410.2174/187152011795347513
  20. Kim Y, Kim WJ, Cha EJ. Quercetin-induced growth inhibition in human bladder cancer cells is associated with an increase in Ca2+-activated K+ channels. Korean J Physiol Pharmacol. 2011; 15:279–83.10.4196/kjpp.2011.15.5.279
  21. Jang SH, Kang KS, Ryu PD, Lee SY. Kv1.3 voltage-gated K+ channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep. 2009; 42:535–9.1971259210.5483/BMBRep.2009.42.8.535
  22. Chin LS, Park CC, Zitnay KM, Sinha M, DiPatri AJ Jr., Perillán P, et al. 4-Aminopyridine causes apoptosis and blocks an outward rectifier K+ channel in malignant astrocytoma cell lines. J Neurosci Res. 1997; 48:122–7.10.1002/(SICI)1097-4547(19970415)48:2<;122::AID-JNR4>3.0.CO;2-E9130140
  23. Ru Q, Tian X, Wu YX, Wu RH, Pi MS, Li CY. Voltage-gated and ATP-sensitive K+ channels are associated with cell proliferation and tumorigenesis of human glioma. Oncol Rep. 2014; 31:842–8.10.3892/or.2013.287524284968
  24. Liu J, Feng S, Zhang L, Wu Z, Chen Q, Cheng W, et al. [Expression and properties of potassium channels in human mammary epithelial cell line MCF10A and its possible role in proliferation]. Sheng Li Xue Bao [Acta Physiologica Sinica]. 2010; 62:203–9. [in Chinese, English abstract].20571736
  25. Leanza L, Henry B, Sassi N, Zoratti M, Chandy KG, Gulbins E, et al. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med. 2012; 4:577–93.2249611710.1002/emmm.201200235
  26. de Guadalupe Chávez-Lòpez M, Hernández-Gallegos E, Vázquez-Sánchez AY, Gariglio P, Camacho J. Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells. Int J Gynecol Cancer. 2014; 24:824–8.10.1097/IGC.000000000000015124819656
  27. Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h.ether-á-gogo K+ channel. Receptors Channels. 2001; 7:345–56.
  28. Breier A, Gibalova L, Seres M, Barancik M, Sulova Z. New insight into p-glycoprotein as a drug target. Anticancer Agents Med Chem. 2013; 13:159–70.2293141310.2174/187152013804487380
  29. Jahchan NS, Dudley JT, Mazur PK, Flores N, Yang D, Palmerton A, et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 2013; 3:1364–77.10.1158/2159-8290.CD-13-018324078773
  30. García-Quiroz J, García-Becerra R, Santos-Martínez N, Barrera D, Ordaz-Rosado D, Avila E, et al. In vivo dual targeting of the oncogenic Ether-á-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors. BMC Cancer. 2014; 14:745, 10.1186/1471-2407-14-745.25280486
  31. Venturini E. Kv1.3 inhibitors in the treatment of glioma and melanoma [doctoral dissertation]. Germany: Universität Duisburg-Essen; 2015.
  32. Stone JR, Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal. 2006; 8:243–70.10.1089/ars.2006.8.24316677071
  33. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002; 165:934–9.1193471710.1164/ajrccm.165.7.2104126
  34. Chattopadhyay MK, Tabor CW, Tabor H. Polyamine deficiency leads to accumulation of reactive oxygen species in a spe2Δ mutant of Saccharomyces cerevisiae. Yeast. 2006; 23:751–61.10.1002/yea.1393
  35. Hermann A, Sitdikova GF, Weiger TM. Oxidative stress and maxi calcium-activated potassium (BK) channels. Biomolecules. 2015; 5:1870–911.10.3390/biom503187026287261
  36. Agostinelli E, Tempera G, Viceconte N, Saccoccio S, Battaglia V, Grancara S, et al. Potential anticancer application of polyamine oxidation products formed by amine oxidase: a new therapeutic approach. Amino Acids. 2010; 38:353–68.10.1007/s00726-009-0431-820012114
  37. Szabó I, Bock J, Grassmé H, Soddemann M, Wilker B, Lang F, et al. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci U S A. 2008; 105:14861–6.1881830410.1073/pnas.0804236105
  38. Jakhar R, Paul S, Bhardwaj M, Kang SC. Astemizole-Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis. Cancer Lett. 2016; 372:89–100.2673906110.1016/j.canlet.2015.12.024
  39. Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol. 1995; 162:163–71.782242710.1002/jcp.1041620202
  40. Ouadid-Ahidouch H, Roudbaraki M, Delcourt P, Ahidouch A, Joury N, Prevarskaya N. Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol. 2004; 287:C125–34.1498523710.1152/ajpcell.00488.2003
  41. Zhang P, Yang X, Yin Q, Yi J, Shen W, Zhao L, et al. Inhibition of SK4 potassium channels suppresses cell proliferation, migration and the epithelial–mesenchymal transition in triple-negative breast cancer cells. PLoS One. 2016; 11:e0154471, 10.1371/journal.pone.0154471.27124117
DOI: https://doi.org/10.1515/abm-2018-0004 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 323 - 330
Published on: Mar 21, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2018 Çağri Öner, Ertuğrul Çolak, Didem Turgut Coşan, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.